- Home
- BELFB vs OCUL Comparison
BELFB vs OCUL Comparison
Compare BELFB & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BELFB | OCUL |
|---|---|---|
| Founded | 1949 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | BELFB | OCUL |
|---|---|---|
| Price | $210.88 | $9.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $164.75 | $22.56 |
| AVG Volume (30 Days) | 156.4K | ★ 4.9M |
| Earning Date | 02-17-2026 | 03-02-2026 |
| Dividend Yield | ★ 0.13% | N/A |
| EPS Growth | ★ 19.52 | N/A |
| EPS | ★ 5.17 | N/A |
| Revenue | ★ $649,376,000.00 | $55,783,000.00 |
| Revenue This Year | $28.52 | N/A |
| Revenue Next Year | $6.49 | $11.96 |
| P/E Ratio | $40.20 | ★ N/A |
| Revenue Growth | ★ 23.70 | N/A |
| 52 Week Low | $58.00 | $5.79 |
| 52 Week High | $214.32 | $16.44 |
Technical Indicators
Market Signals| Indicator | BELFB | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 72.48 | 34.22 |
| Support Level | $193.65 | $10.15 |
| Resistance Level | $214.32 | $11.13 |
| Average True Range (ATR) | 8.00 | 0.85 |
| MACD | 0.96 | -0.06 |
| Stochastic Oscillator | 89.27 | 3.15 |
Price Performance
Historical ComparisonAbout BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.